Allan Doctor, MD
Disclosures: Intellectual property rights/patent holder-KaloCyte, Inc.|Ownership interest (excluding diversified mutual funds)-KaloCyte, Inc.|Supported/contracted research-KaloCyte, Inc. |Royalties or honoraria-Fresenius Kabi AG|Ownership interest (excluding diversified mutual funds)-Etiometry, Inc.|Supported/contracted research-Entegrion, Inc.|Royalties or honoraria-Biogen Idec

Allan Doctor, MD is Professor of Pediatrics and Biochemistry & Molecular Biophysics at the Washington University School of Medicine and a Pediatric Intensivist at Saint Louis Children’s Hospital, where he led Critical Care for 10 years, stepping down in 2016 to focus on a rapidly expanding research program and on development of a novel bio-synthetic artificial red cell. His laboratory studies the role of red blood cell-based signaling in the control of regional blood flow, related pathophysiology arising from acquired red cell injuries, blood substitute design, and on translational transfusion medicine in critical illness.